AnyPlace MD powered by MDBox Pop-Up COVID-19 Testing Details
The joint venture between AnyPlace MD and Reliant Immune Diagnostics, called AnyPlace MD powered by MDBox, is offering access to medical care through onsite medical services and telemedicine visits. Improving patient access to affordable, efficient, and quality healthcare is our forte. Our virtual visits are "symptoms-based," so patients "find their way" into our telemedicine services because of their immediate and personal medical needs. Before the COVID-19 pandemic, our telemedicine platform was well on its way with state-of-the-art technology and proven visit success.
When the COVID-19 pandemic hit the scene, our founders recognized the need for a quick and impactful response. Our clinical scientists, medical teams, and software engineers were summoned to determine the best way to help the hardest-hit populations. The idea of a Pop-Up (literally) testing event, complete with a connection to a telemedicine visit, was born. We purchased rapid serology test kits, which were made available for commercialization through the legal process set forth by the FDA for serology tests. Our clinical scientists conducted a review and validation process to assist us in test kit selection. Our COVID-19 Pop-Up Testing Visit is unique from other COVID-19 drive-through visits in that we offer the services of onsite healthcare professionals and licensed telemedicine providers who diagnose and counsel the patient.
We will be evaluating patients for COVID-19 infection using two different tests:
The SARS-CoV-2 Serology or Antibody Test
The SARS-CoV-2 serology test is a rapid finger-prick blood test that detects antibodies against the virus.
The test used by AnyPlace MD powered by MDBox has been designed to be very specific for the SARS-CoV-2 virus. It helps us determine whether the patient has been exposed to the virus and if they are developing antibodies to the virus.
Antibodies against SARS-CoV 2 virus are detectable early in the course of infection, usually about 5-10 days after symptoms begin, and may be indicative of developing immunity. Some patients infected with SARS-CoV-2 virus never develop symptoms, but still, make antibodies. These people are called "asymptomatic carriers." Antibody tests can be useful in understanding how many people have been infected or exposed and how far the pandemic has progressed. The data we receive from antibody testing holds the key to understanding SARS-CoV-2 and pandemics in general.
The Molecular or PCR Test
Antibody tests by themselves are of limited value for the individual patient. They don't always give us an answer about where the patient is in their disease process. Therefore, AnyPlace MD powered by MDBox will also be offering a molecular test to confirm the diagnosis of COVID-19 infection. The molecular test is called a "Reverse Transcriptase Polymerase Chain Reaction Test (RT-PCR test)." PCR tests are used to directly detect the presence of viral RNA in the bloodstream. By detecting viral RNA, which will be present in the body before antibodies form or symptoms of the disease are present, the tests can tell whether or not someone has the infection very early on.
By using both the antibody and molecular types of tests, we can accurately diagnose and counsel our patients. Those with positive PCR tests and positive antibody tests can be isolated from others. They will be advised to notify their contacts so that they can also be quarantined.
When performed on large numbers of people, Molecular (PCR) and Antibody Testing can give a snapshot of community spread and increase our knowledge about the pandemic. AnyPlace MD powered by MDBox Pop-Up COVID-19 Testing will combine the medical skills of our telemedicine professionals and the scientific expertise of our clinical scientists. We hope to make a significant impact on the COVID-19 pandemic while serving the individual healthcare needs of our patients.